SFS
IRWD icon

Sowell Financial Services’s Ironwood Pharmaceuticals IRWD Stock Holding History

Sowell Financial Services’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,755
Closed -$18K – 1604
2021
Q1 		$18K Buy
1,755
+605
+53% +$6.39K ﹤0.01% 2093
2020
Q4 		$13K Buy
+1,150
New +$12.6K ﹤0.01% 1914

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Sowell Financial Services's IRWD Position: Q2 2021 in Review

Sowell Financial Services sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2021, closing a stake of 1,755 shares — an estimated $18K sold.

Sowell Financial Services first reported a position in IRWD in Q4 2020 and held it in 2 quarters. The position peaked at $18K in Q1 2021. 209 funds tracked by Wall St. Rank hold IRWD as of Q2 2021.

  • Sowell Financial Services reported no remaining Ironwood Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 1,755 Ironwood Pharmaceuticals shares in Q2 2021, an estimated $18K.
  • Sowell Financial Services first reported a position in Ironwood Pharmaceuticals in Q4 2020 and held it in 2 quarters.
  • Sowell Financial Services's Ironwood Pharmaceuticals position peaked at $18K in Q1 2021.
  • 209 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.